Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

Shaping healthcare

Shaping healthcare Or with our other big growth product Eylea, a VEGF treatment for the retina, we have 80, 000 patients under treatment as we speak.

Pharma sales help Bayer escape the worst from a bumpy 2017

Pharma sales help Bayer escape the worst from a bumpy 2017 Together they brought in just over 6.5bn, although Xarelto and Eylea accounted for over 80% of the total. ... Among them were a 7, 000 patient study of Xarelto in secondary stroke, a combination trial of Eylea and a drug-device combination for pneumonia.

The good, the bad and the ugly

The good, the bad and the ugly Bayer’s growth - a healthy 14.6% - was stimulated by a steady performance by Xarelto in Europe and Asia, and strong sales of its eye medicine Eylea in Japan, Europe and ... Regeneron remains the leading player, with 10% growth in 2017 thanks to

Regeneron and Bayer drop AMD combination

Regeneron and Bayer drop AMD combination Adding nesvacumab to Eylea did not however add enough additional benefit to warrant further development. ... Meanwhile, Novartis is making much of the fact that brolucizumab only needs to be dosed every 12 weeks, rather than every eight weeks for Eylea.

NICE first fast-track appraisal backs Bayer's Eylea

NICE first fast-track appraisal backs Bayer's Eylea The National Institute for Health and Care Excellence (NICE) has issued its first fast-track guidance, recommending Bayer’s Eylea (aflibercep) in choroidal neovascularisation (CNV). ... The final guidance on Eylea is due to be published on 1 November

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics